News
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
Moderna’s new influenza vaccine, based on the same mRNA technology used in its COVID-19 vaccine, showed promising results in a major trial.
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...
Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results